Sensei Biotherapeutics Inc SNSE Q1 2026 Earnings Deep EPS Miss Reflects Heavy RD Investment and PreRevenue Status IRON Q1 2026 Earnings Narrower Loss Beats Estimates as Disc Medicine Advances Clinical Pipeline MDXG Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Ally Financial Q1 2026 Earnings EPS Surpasses Estimates by 165 Shares Edge Higher KOS Q1 2026 Earnings EPS Miss Weighs on Shares as Operating Environment Challenges Persist AFYA Q1 2026 Earnings EPS Miss Weighs on Shares Despite Solid Operational Progress